Drug update: emerging therapies for breast cancer.
Valgus
J M
JM
Philadephia College of Pharmacy and University of the Sciences in Philadelphia, PA, USA.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004358:Drug Therapy / Q000639:trends*; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D013629:Tamoxifen; D003841:Deoxycytidine; D020849:Raloxifene Hydrochloride; D000069287:Capecitabine; D000068878:Trastuzumab; D005472:Fluorouracil